BeOne Medicines AG
ONC
$316.99
-$5.38-1.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.48B | 1.40B | 1.32B | 1.12B | 1.12B |
| Total Other Revenue | 21.73M | 17.27M | -- | -- | 9.79M |
| Total Revenue | 1.50B | 1.41B | 1.32B | 1.12B | 1.13B |
| Cost of Revenue | 142.42M | 196.51M | 164.61M | 165.00M | 160.56M |
| Gross Profit | 1.36B | 1.22B | 1.15B | 952.28M | 967.26M |
| SG&A Expenses | 555.29M | 529.00M | 537.91M | 459.29M | 504.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.31B | 1.25B | 1.23B | 1.11B | 1.21B |
| Operating Income | 185.04M | 163.11M | 87.89M | 11.10M | -79.43M |
| Income Before Tax | 149.24M | 147.16M | 99.55M | 20.90M | -85.35M |
| Income Tax Expenses | 82.74M | 22.32M | 5.23M | 19.63M | 66.53M |
| Earnings from Continuing Operations | 66.50M | 124.84M | 94.32M | 1.27M | -151.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 66.50M | 124.84M | 94.32M | 1.27M | -151.88M |
| EBIT | 185.04M | 163.11M | 87.89M | 11.10M | -79.43M |
| EBITDA | 219.47M | 198.86M | 117.75M | 42.73M | -30.36M |
| EPS Basic | 7.81 | 14.73 | 11.32 | 0.15 | -18.58 |
| Normalized Basic EPS | 1.07 | 0.91 | 0.59 | 0.13 | -0.46 |
| EPS Diluted | 6.80 | 13.52 | 10.14 | 0.15 | -18.75 |
| Normalized Diluted EPS | 1.03 | 0.88 | 0.57 | 0.13 | -0.46 |
| Average Basic Shares Outstanding | 110.73M | 110.22M | 108.32M | 106.93M | 106.26M |
| Average Diluted Shares Outstanding | 8.88M | 8.81M | 8.66M | 8.55M | 8.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |